Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 2
2011 2
2012 3
2013 1
2014 3
2015 1
2016 3
2017 5
2018 3
2019 1
2020 3
2021 3
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Pathophysiological consequences of isoform-specific IP3 receptor mutations.
Kerkhofs M, Seitaj B, Ivanova H, Monaco G, Bultynck G, Parys JB. Kerkhofs M, et al. Among authors: ivanova h. Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1707-1717. doi: 10.1016/j.bbamcr.2018.06.004. Epub 2018 Jun 12. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 29906486 Free article. Review.
Mutations Associated with Imatinib Mesylate Resistance - Review.
Linev AJ, Ivanov HJ, Zhelyazkov IG, Ivanova H, Goranova-Marinova VS, Stoyanova VK. Linev AJ, et al. Among authors: ivanova h. Folia Med (Plovdiv). 2018 Dec 1;60(4):617-623. doi: 10.2478/folmed-2018-0030. Folia Med (Plovdiv). 2018. PMID: 31188765 Review.
Bcl-xL acts as an inhibitor of IP3R channels, thereby antagonizing Ca2+-driven apoptosis.
Rosa N, Ivanova H, Wagner LE 2nd, Kale J, La Rovere R, Welkenhuyzen K, Louros N, Karamanou S, Shabardina V, Lemmens I, Vandermarliere E, Hamada K, Ando H, Rousseau F, Schymkowitz J, Tavernier J, Mikoshiba K, Economou A, Andrews DW, Parys JB, Yule DI, Bultynck G. Rosa N, et al. Among authors: ivanova h. Cell Death Differ. 2022 Apr;29(4):788-805. doi: 10.1038/s41418-021-00894-w. Epub 2021 Nov 8. Cell Death Differ. 2022. PMID: 34750538 Free PMC article.
Expanding the chemical space of 3(5)-functionalized 1,2,4-triazoles.
Khomenko DM, Doroshchuk RO, Ohorodnik YM, Ivanova HV, Zakharchenko BV, Raspertova IV, Vaschenko OV, Dobrydnev AV, Grygorenko OO, Lampeka RD. Khomenko DM, et al. Among authors: ivanova hv. Chem Heterocycl Compd (N Y). 2022;58(2-3):116-128. doi: 10.1007/s10593-022-03064-z. Epub 2022 Mar 23. Chem Heterocycl Compd (N Y). 2022. PMID: 35340781 Free PMC article.
33 results